Stock Club

#250: Hims & Hers Stock Plummets 35% – Is Now the Time to Buy?


Listen Later

This year has been a wild one for Hims & Hers. Thanks to the shortage of GLP-1 weight loss drugs such as Ozempic, Wegovy, and Zepbound, Hims was able to sell an unapproved compounded semaglutide. This caused sales to soar, with revenue up 95% in its most recent quarter. However, Hims' luck may have run out, as the U.S. FDA announced that the drug shortage is over and that it will clamp down on unapproved semaglutide. Is the sell-off justified, or is this a great time for investors to grab a piece of the pie?


Keeping with the bioscience theme, Emmet unpacks the recent sell-off of genetics company Illumina. Once a darling of the market—up 110x since its debut—the stock is now down 80% from its all-time high.


To wrap up, Mike and Emmet break down the recent announcement that deemed disposal and the higher ETF tax rate will be reviewed under Budget 2026. Let the Irish rejoice.



MyWallSt’s Horizon service follows founder, long-term investor, and beloved podcaster Emmet Savage. This week, Emmet will be pitching a stock that has seen revenue surge 200% since 2021 and has just secured a lucrative government contract.


A few lucky podcast listeners can grab an exclusive discount and unlock this stock and other future 100-baggers.


To grab this deal, email us at [email protected]

Don’t wait.

[email protected]



Become a successful investor by checking out all the content MyWallSt has to offer:

📩 Email us: [email protected]

📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7

💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/

🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/

🎉 Follow MyWallSt on social:

🐦 Twitter: @MyWallStHQ

💃 TikTok: @MyWallSt

📸 Instagram: @MyWallSt

🖥️ Facebook: @MyWallSt

👔 LinkedIn: MyWallSt



00:00 Intro

05:30 Illumina: A Tale of Two Investors

26:55 Hims & Hers: Telehealth and Weight Loss Drugs

33:49 Hims & Hers: Earnings Report and Future Guidance

46:11 Irish Tax Changes and Investment Landscape


Hosted on Acast. See acast.com/privacy for more information.

...more
View all episodesView all episodes
Download on the App Store

Stock ClubBy MyWallSt

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

86 ratings


More shows like Stock Club

View all
Mad Money w/ Jim Cramer by CNBC

Mad Money w/ Jim Cramer

4,088 Listeners

Motley Fool Money by The Motley Fool

Motley Fool Money

3,223 Listeners

We Study Billionaires - The Investor’s Podcast Network by The Investor's Podcast Network

We Study Billionaires - The Investor’s Podcast Network

3,386 Listeners

Rule Breaker Investing by The Motley Fool

Rule Breaker Investing

948 Listeners

Investing Insights by Morningstar

Investing Insights

523 Listeners

Best Stocks Now with Bill Gunderson by Bill Gunderson

Best Stocks Now with Bill Gunderson

362 Listeners

Zacks Market Edge by Zacks Investment Research

Zacks Market Edge

294 Listeners

The Investing for Beginners Podcast - Your Path to Financial Freedom by By Andrew Sather and Dave Ahern | Stock Market Guide to Buying Stocks like

The Investing for Beginners Podcast - Your Path to Financial Freedom

1,417 Listeners

Chit Chat Stocks by Chit Chat Stocks

Chit Chat Stocks

192 Listeners

The Intrinsic Value Podcast - The Investor’s Podcast Network by The Investor's Podcast Network

The Intrinsic Value Podcast - The Investor’s Podcast Network

559 Listeners

Barron's Streetwise by Barron's

Barron's Streetwise

1,557 Listeners

Barron's Live by Barron's Live

Barron's Live

208 Listeners

Daily Stock Market News by Markus Heitkoetter

Daily Stock Market News

54 Listeners

Investing Experts by Seeking Alpha

Investing Experts

67 Listeners

Stock Market Today With IBD by Investor's Business Daily

Stock Market Today With IBD

44 Listeners